Clinical Trial Update: Comparison of the Subjective Well-being and Tolerability of Quetiapine XR to Risperidone [Phase 3]

View source ↗

Summary

A Phase 3 head-to-head trial compared quetiapine XR with risperidone in schizophrenia, focusing on subjective well-being and tolerability; results have been pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Quetiapine XR (quetiapine)
• Risperdal (risperidone)

Snippet

Sponsor: AstraZeneca | Conditions: Schizophrenic Disorders | Phase 3 | Status: COMPLETED | Results posted: 2012-09-12